AirNexis Therapeutics
PrivateLast Round
Series A
Mar 9, 2026
Est. Valuation
$341.7M
Total Funding Raised
$200M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
AirNexis Therapeutics is a biotechnology company developing clinical-stage therapies for chronic obstructive pulmonary disease (COPD) and other pulmonary conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AirNexis Therapeutics Comparables
Compare AirNexis Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Merck & Co., Inc. | 83% | |
| AeroRx Therapeutics | 82% | |
| Aeriant Therapeutics AB | 78% | |
AirNexis Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Mar 9, 2026 | ||||
| Series A | Jan 9, 2026 |
AirNexis Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Longitude Capital | Series A |
| Enavate Sciences | Series A |
| Life Sciences at Goldman Sachs Alternatives | Series A |
| OrbiMed | Series A |
| Frazier Life Sciences | Series A |
| SR One | Series A |
| Goldman Sachs Alternatives | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 27, 2026
Grew 150% QoQ, from 4 to 10 employees.
- Mar 9, 2026
$62M round completed.
AirNexis Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about AirNexis Therapeutics's valuation, stock price, and market status.